Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Fox Corporation (FOX) names Puja Vohra as CMO and EVP
-
Trump urges Fed Chair Powell to cut rates after ADP jobs data release
-
ADP Employment Change (May) 37K vs 114K Expected
-
Vera Therapeutics Inc. (VERA) Reports Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
Revelation Biosciences (REVB) announces Board retirement
-
Essent Group (ESNT) Announces 2 New Directors of the Board
-
MercadoLibre (MELI) CEO transitions to Executive Chairman
-
VSee Health (VSEE) launches Project MAMA, AI-powered telehealth initiative
-
Luminar Technologies (LAZR) appoints Paul Ricci as new CEO
-
Form 4 GLEN BURNIE BANCORP For: Jun 14 Filed by: Hess Stanford
-
Knight-Hennessy Scholars announces 2025 cohort of new scholars
-
Cisco Systems (CSCO) Appoints Kevin Weil to its Board
-
Stanford Department of Health Policy: When Healthcare Providers Go Bankrupt, Patients Pay the Price
-
Corvus Pharma (CRVS) Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
-
Charles River Laboratories (CRL) Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
-
IONQ Inc (IONQ) Appoints Jordan Shapiro as President and General Manager, Quantum Networking
-
HeartBeam, Inc (BEAT) Appoints CEO Robert Eno to its Board
-
Biogen (BIIB) PT Lowered to $187 at H.C. Wainwright
-
Sinclair Broadcast Group (SBGI) Appoints Jeff Blackburn Chairman and CEO of Tennis Channel
-
ADP Employment Change (Apr) 62K vs 115K Expected
-
Amylyx Pharmaceuticals (AMLX) Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
-
Guardant Health (GH) Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types
-
ArriVent BioPharma (AVBP) Appoints Merdad Parsey to its Board
-
Rimini Street, Inc. (RMNI) Appoints Joe Locandro as EVP and Chief Information Officer
-
Autodesk (ADSK) Appoints Jeff Epstein and Christie Simons to its Board
-
Texas Capital Bancshares (TCBI) Appoints Ranjana B. Clark to its Board
-
Sight Sciences (SGHT) appoints Gary Burbach to Board
-
Climb Global Solutions (CLMB) Appoints Paul Giovacchini to its Board
-
Google's journey from dorm to internet dominance
-
Uniti Group (UNIT) nominates Harold Zeitz for Board election
-
Beyond Air, Inc. (XAIR) subsidiary NeuroNOS appoints Dan Shechtman to SAB
-
First American Financial (FAF) Appoints Mark E. Seaton as CEO
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
TG Therapeutics (TGTX) Announces Two Publications Highlighting BRIUMVI in Medical Journals
-
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
-
Stanford MD Reveals Game-Changing Survival Guide for Working Mothers, Arriving April 5
-
Greenwich LifeSciences (GLSI) Provides Global Update on FLAMINGO-01
-
ADP Employment Change (Mar) 155K vs 120K Expected
-
BridgeBio Pharma (BBIO) Reports Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
-
Bicycle Therapeutics (BCYC) Announces New Board and Key Clinical Leadership Appointments
-
Adeia (ADEA) nominates Sandeep Vij for Board
-
Quantum Computing Inc (QUBT) Announces Appointment of Eric Schwartz to Board of Directors
-
Stanford Health Care Employee Files New Lawsuit Alleging Medical Whistleblower Retaliation and Race Discrimination and Fraudulently Concealed Defamation Against Stanford University and Stanford Health
-
RenovoRx (RNXT) Pre-Clinical Results Supporting TAMP as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting
-
Fed's Kugler: Paying Close Attention To Acceleration Of Price Increases And Higher Inflation Expectations
-
GrabAGun (PSQH) Nominates Donald Trump Jr. and Post-Closing Board of Directors and Advances Plans for Upcoming Public Listing
-
Elicio Therapeutics (ELTX) Appoints Preetam Shah as Chief Strategy and Financial Officer
-
NanoDefense Pro Reviews (URGENT) Investigative Report Examines Safety Concerns and Customer Reports

